本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mereo Biopharma Group Plc

2.50
+0.17007.30%
盘后2.500.00000.00%16:05 EDT
成交量:235.59万
成交额:583.85万
市值:3.98亿
市盈率:-8.55
高:2.55
开:2.36
低:2.33
收:2.33
数据加载中...
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/10/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/19

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/05/26

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans